Co-design of Guidance for Patient and Public Involvement in Psychedelic Research

被引:8
作者
Close, James B. [1 ]
Bornemann, Julia [1 ]
Piggin, Maria [2 ]
Jayacodi, Sandra [3 ]
Luan, Lisa Xiaolu [1 ]
Carhart-Harris, Robin [1 ]
Spriggs, Meg Jo [1 ]
机构
[1] Imperial Coll London, Ctr Psychedel Res, Div Brain Sci, London, England
[2] Imperial Coll London, Patient Experience Res Ctr, London, England
[3] Imperial Biomed Res Ctr Publ Panel, London, England
来源
FRONTIERS IN PSYCHIATRY | 2021年 / 12卷
关键词
psychedelics; research; patient; public; involvement; PPI; guideline; strategy; LIFE-THREATENING CANCER; PSILOCYBIN TREATMENT; ANXIETY; DEPRESSION; HEALTH; PSYCHOTHERAPY; CHALLENGES;
D O I
10.3389/fpsyt.2021.727496
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Within the context of scientific research, patient and public involvement (PPI) is defined as research performed "with" or "by" patients and members of the public, rather than "to," "about", or "for" them. When carried out systematically and thoughtfully, PPI has the potential to strengthen the quality and impact of research by fostering accountability, transparency, and relevance. There exist numerous guidelines, frameworks and tools for supporting PPI, however, these do not account for the unique challenges faced in psychedelic research. This paper describes the co-design of guidance intended to help build, evaluate and improve PPI in psychedelic research. A steering group was formed to design and run a co-design workshop alongside public collaborators. Insights from this workshop were analyzed and refined into a comprehensive and readily usable guide for planning PPI specific to the field of psychedelic research. Core values emerging from the process focused on the essential importance of trust, learning, purpose and inclusivity. It is hoped that this guidance will be a starting point for incorporating PPI in future psychedelic research, so that it can grow and adapt as this burgeoning field of research progresses.
引用
收藏
页数:10
相关论文
共 77 条
  • [1] Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer
    Agin-Liebes, Gabrielle, I
    Malone, Tara
    Yalch, Matthew M.
    Mennenga, Sarah E.
    Ponte, K. Linnae
    Guss, Jeffrey
    Bossis, Anthony P.
    Grigsby, Jim
    Fischer, Stacy
    Ross, Stephen
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2020, 34 (02) : 155 - 166
  • [2] Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies
    Andersen, Kristoffer A. A.
    Carhart-Harris, Robin
    Nutt, David J.
    Erritzoe, David
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 2021, 143 (02) : 101 - 118
  • [3] [Anonymous], 2012, BRIEFING NOTES RES P
  • [4] A patient and public involvement (PPI) toolkit for meaningful and flexible involvement in clinical trials – a work in progress
    Bagley H.J.
    Short H.
    Harman N.L.
    Hickey H.R.
    Gamble C.L.
    Woolfall K.
    Young B.
    Williamson P.R.
    [J]. Research Involvement and Engagement, 2 (1)
  • [5] Inside co-production: Ruling, resistance, and practice
    Bevir, Mark
    Needham, Catherine
    Waring, Justin
    [J]. SOCIAL POLICY & ADMINISTRATION, 2019, 53 (02) : 197 - 202
  • [6] Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
    Bogenschutz, Michael P.
    Forcehimes, Alyssa A.
    Pommy, Jessica A.
    Wilcox, Claire E.
    Barbosa, P. C. R.
    Strassman, Rick J.
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2015, 29 (03) : 289 - 299
  • [7] Mapping the impact of patient and public involvement on health and social care research: a systematic review
    Brett, Jo
    Staniszewska, Sophie
    Mockford, Carole
    Herron-Marx, Sandra
    Hughes, John
    Tysall, Colin
    Suleman, Rashida
    [J]. HEALTH EXPECTATIONS, 2014, 17 (05) : 637 - 650
  • [8] Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
    Carhart-Harris, R. L.
    Bolstridge, M.
    Day, C. M. J.
    Rucker, J.
    Watts, R.
    Erritzoe, D. E.
    Kaelen, M.
    Giribaldi, B.
    Bloomfield, M.
    Pilling, S.
    Rickard, J. A.
    Forbes, B.
    Feilding, A.
    Taylor, D.
    Curran, H. V.
    Nutt, D. J.
    [J]. PSYCHOPHARMACOLOGY, 2018, 235 (02) : 399 - 408
  • [9] Trial of Psilocybin versus Escitalopram for Depression
    Carhart-Harris, Robin
    Giribaldi, Bruna
    Watts, Rosalind
    Baker-Jones, Michelle
    Murphy-Beiner, Ashleigh
    Murphy, Roberta
    Martell, Jonny
    Blemings, Allan
    Erritzoe, David
    Nutt, David J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (15) : 1402 - 1411
  • [10] Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
    Carhart-Harris, Robin L.
    Bolstridge, Mark
    Rucker, James
    Day, Camilla M. J.
    Erritzoe, David
    Kaelen, Mendel
    Bloomfield, Michael
    Rickard, James A.
    Forbes, Ben
    Feilding, Amanda
    Taylor, David
    Pilling, Steve
    Curran, Valerie H.
    Nutt, David J.
    [J]. LANCET PSYCHIATRY, 2016, 3 (07): : 619 - 627